Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on September 2, 2025
A Key Growth Driver for Lyocell Fibers Market, Trends and Forecast, 2031
EIN Presswire
·
September 2, 2025
The global lyocell fibers market size is projected to reach $2.7 billion by 2031, growing at a CAGR of 8.2% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- Global Lyocell fibers market report provides a detailed …
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
GlobeNewswire
·
September 2, 2025
GAITHERSBURG, Md., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $30 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the …
Constellation Brands Updates Fiscal 2026 Outlook
GlobeNewswire
·
September 2, 2025
Updates reported EPS guidance to $10.77 - $11.07 and comparable EPS guidance to $11.30 - $11.60 (1) Updates Enterprise organic net sales to decline (6)% - (4)%, reported operating income to grow 666% - 686% and comparable operating income to decline (11)% …
Habit Burger & Grill Unveils Its New Sirloin Steak Sandwich
GlobeNewswire
·
September 2, 2025
IRVINE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Habit Burger …
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
CLEVELAND, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule …
BridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical Hypoparathyroidism
GlobeNewswire
·
September 2, 2025
PALO ALTO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that an oral presentation of Phase 2 data in …
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
GlobeNewswire
·
September 2, 2025
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress YAVNE, Israel, September 2, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue …
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism
GlobeNewswire
·
September 2, 2025
Open-label study in as few as 16 tumor hyperinsulinism (HI) patients Study initiated and enrolling patients in the U.S. and Europe Topline data expected in the second half of 2026 REDWOOD CITY, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. ( …
CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team
GlobeNewswire
·
September 2, 2025
- Transformational deal for CorMedix that expands and diversifies company’s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potential - - Revised guidance of pro forma 2025 …
Dragonfly Energy Announces Updated Corporate Presentation
GlobeNewswire
·
September 2, 2025
RENO, Nev., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced that an updated corporate presentation is now …
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025
GlobeNewswire
·
September 2, 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, …
ASP Isotopes Issues Letter to Shareholders
GlobeNewswire
·
September 2, 2025
WASHINGTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple …
Digi Power X Expands Digital Asset Holdings and Accelerates Pivot to AI Infrastructure with Alabama Build-Out and Reports August 2025 Production Results
GlobeNewswire
·
September 2, 2025
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“ …
Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak
GlobeNewswire
·
September 2, 2025
Your vote is important regardless of the number of Shares you own. Board unanimously recommends shareholders vote “FOR” the Arrangement. Shareholders are encouraged to review the circular carefully and submit their proxies in advance of the proxy voting …
Theratechnologies annonce que les agences de conseil en vote indépendantes ISS et Glass Lewis recommandent aux actionnaires de voter « EN FAVEUR » du plan d’arrangement prévu avec Future Pak
GlobeNewswire
·
September 2, 2025
Votre vote est important, quel que soit le nombre d’actions que vous détenez. Le conseil d’administration recommande à l’unanimité aux actionnaires de voter EN FAVEUR de l’arrangement. Les actionnaires sont invités à lire attentivement la circulaire et à …
Avicanna LATAM SAS Teams Up With Harrington Wellness to Launch re+PLAY CBD Wellness Brand Topicals in the United States
GlobeNewswire
·
September 2, 2025
re+PLAY is a CBD wellness brand founded by NBA veteran Al Harrington with products utilizing Avicanna’s patented and proprietary CBD formulations. The initial launch of re+PLAY in the United States includes two products available at Harrington Wellness’ …
NANO Nuclear Energy Awarded AFWERX Direct to Phase II Contract for KRONOS MMR™ RDT&E at Joint Base Anacostia-Bolling
GlobeNewswire
·
September 2, 2025
NANO Nuclear chosen to conduct a research, development, test and evaluation effort aimed at deploying a KRONOS MMR™ Energy System at Washington, D.C. military base Figure 1- NANO Nuclear Energy Awarded AFWERX Direct to Phase II Contract for KRONOS MMR™ RDT …
Alterity Therapeutics to Present at the Biotech Showcase
GlobeNewswire
·
September 2, 2025
MELBOURNE, Australia and SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …
SubQuery Announces 100M $SQT Consumer Rewards Pool
GlobeNewswire
·
September 2, 2025
Singapore, Sept. 02, 2025 (GLOBE NEWSWIRE) -- SubQuery has announced an update to its Consumer Rewards Programme, which now totals 100 million $SQT. The company has added Decentralised RPCs (dRPCs) to the scheme, allocating 40 million $SQT specifically to …
Hammond Power Solutions Provides Update on U.S. Tariff Changes
GlobeNewswire
·
September 2, 2025
GUELPH, Ontario, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) has determined that the recently expanded U.S. tariffs on steel and aluminum derivative products apply to certain materials and …